Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

21. Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial

Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial 30422259 2018 11 13 2168-6238 2018 Nov 07 JAMA psychiatry JAMA Psychiatry Effect of a Lay Counselor Intervention on Prevention of Major Depression in Older Adults Living in Low- and Middle-Income Countries: A Randomized Clinical Trial. 10.1001/jamapsychiatry.2018.3048 Preventing depression in older adults living in low- and middle (...) -income countries is important because of the scarcity of treatment resources and the risk of disability, suicide, and dementia. To assess whether an intervention for depression prevention provided by lay counselors is effective in older adults from low- and middle-income countries. This parallel-group randomized clinical trial with masked outcome assessment was performed in 181 older adults (≥60 years) with subsyndromal depressive symptoms at rural and urban primary care clinics in Goa, India

EvidenceUpdates2018

22. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis

Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis 30427999 2018 11 14 2168-6238 2018 Nov 14 JAMA psychiatry JAMA Psychiatry Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. 10.1001/jamapsychiatry.2018.2734 Countering depressive disorders is a public health priority. Currently, antidepressants are the first-line treatment, although they show modest (...) effects. In men, testosterone treatment is a controversial alternative or adjunct treatment option. To examine the association of testosterone treatment with alleviation of depressive symptoms in men and to clarify moderating effects of testosterone status, depression status, age, treatment duration, and dosage. English-language studies published in peer-reviewed journals identified from PubMed/Medline, Embase, Scopus, PsychINFO, and the Cochrane Controlled Trials Register from database inception

EvidenceUpdates2018

23. WITHDRAWN: Psychotherapy for depression among incurable cancer patients.

WITHDRAWN: Psychotherapy for depression among incurable cancer patients. BACKGROUND: The most common psychiatric diagnosis among cancer patients is depression; this diagnosis is even more common among patients with advanced cancer. Psychotherapy is a patient-preferred and promising strategy for treating depression among cancer patients. Several systematic reviews have investigated the effectiveness of psychological treatment for depression among cancer patients. However, the findings (...) are conflicting, and no review has focused on depression among patients with incurable cancer. OBJECTIVES: To investigate the effects of psychotherapy for treating depression among patients with advanced cancer by conducting a systematic review of randomized controlled trials (RCTs). SEARCH METHODS: We searched the Cochrane Pain, Palliative and Supportive Care Group Register, The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, and PsycINFO databases in September 2005. SELECTION CRITERIA: All

Cochrane2018

24. Overview of depression

Overview of depression Overview of depression - Summary of relevant conditions | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Overview of depression Last reviewed: October 2018 Last updated: November 2018 Introduction Depression is a mental state characterised by persistent low mood, loss of interest and enjoyment in everyday activities, neurovegetative disturbance, and reduced energy, causing varying levels of social and occupational dysfunction (...) . Depressive disorders are common in people of all ages and may be classified depending on the duration, severity, and number of symptoms, and the degree of functional impairment. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013. In bipolar disorder, a manic episode may have been preceded by and may be followed by hypomanic or major depressive episodes. American Psychiatric Association. Diagnostic

BMJ Best Practice2018

25. Depression.

Depression. Major depression is a common illness that severely limits psychosocial functioning and diminishes quality of life. In 2008, WHO ranked major depression as the third cause of burden of disease worldwide and projected that the disease will rank first by 2030. 1 In practice, its detection, diagnosis, and management often pose challenges for clinicians because of its various presentations, unpredictable course and prognosis, and variable response to treatment.

Lancet2018

26. Indicated preventive interventions for depression in children and adolescents: A meta-analysis and meta-regression

Indicated preventive interventions for depression in children and adolescents: A meta-analysis and meta-regression 30287331 2018 11 16 1096-0260 118 2018 Oct 02 Preventive medicine Prev Med Indicated preventive interventions for depression in children and adolescents: A meta-analysis and meta-regression. 7-15 S0091-7435(18)30299-8 10.1016/j.ypmed.2018.09.021 Depression contributes about 2% to the global burden of disease. A first onset of depressive disorder or subsyndromal depressive symptoms (...) is common in adolescence, indicating that early prevention is a priority. However, trials of preventive interventions for depression in youths show conflicting results. This systematic review and meta-analysis investigated the effectiveness of group-based cognitive behavioral therapy (GB-CBT) as a preventive intervention targeting subsyndromal depression in children and adolescents. In addition, the impact of different covariates (type of comparator and use of booster sessions) was assessed. Relevant

EvidenceUpdates2018

27. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression

Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression 30337374 2018 10 19 1468-3288 2018 Oct 18 Gut Gut Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. gutjnl-2018-317182 10.1136/gutjnl-2018-317182 Depression is associated with IBD, but the effect of antidepressants on IBD has been sparsely studied. We (...) assessed the impact of depression and antidepressant therapies on the development of IBD. The Health Improvement Network (THIN) was used to identify a cohort of patients with new-onset depression from 1986 to 2012. THIN patients who did not meet the defining criteria for depression were part of the referent group. The outcome was incident Crohn's disease (CD) or ulcerative colitis (UC). Cox proportional hazards modelling was performed to evaluate the rate of Crohn's disease or UC development among

EvidenceUpdates2018

28. Screening for Perinatal Depression

Screening for Perinatal Depression INTERIM UPDATE ACOGCOMMITTEEOPINION Number 757 (Replaces Committee Opinion No. 630, May 2015) Committee on Obstetric Practice This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. INTERIM UPDATE: This Committee Opinion is updated as highlighted to reflect a limited, focused change in the language and supporting evidence regarding prevalence, benefits of screening, and screening tools (...) . Screening for Perinatal Depression ABSTRACT: Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects. Several screening instruments

American College of Obstetricians and Gynecologists2018

29. Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study

Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study Article Text Original article Acceptability of the Fitbit in behavioural activation therapy

Evidence-Based Mental Health2018 Full Text: Link to full Text with Trip Pro

30. Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). OBJECTIVE: To investigate the effectiveness of combining mirtazapine with serotonin-noradrenaline reuptake inhibitor (SNRI) or selective serotonin reuptake inhibitor (SSRI) antidepressants for treatment resistant depression in primary care. DESIGN: Two parallel group multicentre phase III randomised placebo controlled trial. SETTING: 106 general practices (...) in four UK sites; Bristol, Exeter, Hull, and Keele/North Staffs, August 2013 to October 2015. PARTICIPANTS: 480 adults aged 18 or more years who scored 14 or more on the Beck depression inventory, second revision, fulfilled ICD-10 (international classification of diseases, 10th revision) criteria for depression, and had used an SSRI or SNRI for at least six weeks but were still depressed. 241 were randomised to mirtazapine and 239 to placebo, both given in addition to usual SSRI or SNRI treatment

BMJ2018 Full Text: Link to full Text with Trip Pro

31. Overseas models of specialist support for primary care physicians in managing depression may not be transferrable to the UK health system

Overseas models of specialist support for primary care physicians in managing depression may not be transferrable to the UK health system Signal - Overseas models of specialist support for primary care physicians in managing depression may not be transferrable to the UK health system Dissemination Centre Discover Portal NIHR DC Discover Overseas models of specialist support for primary care physicians in managing depression may not be transferrable to the UK health system Published on 11 (...) or may not have direct contact with the patient. Half of the trials were from the USA, where specialist care is normal for illness of all severity, and only one from the UK. Relevance to the NHS is likely to be limited. Most studies were in people with depression with limited evidence available for other mental health conditions. Evidence was strongest for an effect on adherence to treatment, with few studies examining effects on patient mental health outcomes. The review did not examine whether

NIHR Dissemination Centre2018

32. People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada

People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada 30349739 2018 11 14 2056-7529 4 2018 Research involvement and engagement Res Involv Engagem People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada. 37 10.1186/s40900-018-0115-1 The Alberta (...) Depression Research Priority Setting Project aimed to meaningfully involve patients, families and clinicians in determining a research agenda aligned to the needs of Albertans who have experienced depression. The project was modeled after a process developed in the UK by the James Lind Alliance and adapted to fit the Alberta, Canada context. This study describes the processes used to ensure the voices of people with lived experience of depression were integrated throughout the project stages. The year

Research involvement and engagement2018 Full Text: Link to full Text with Trip Pro

33. Demographic and clinical predictors of response to internet-enabled cognitive–behavioural therapy for depression and anxiety

Demographic and clinical predictors of response to internet-enabled cognitive–behavioural therapy for depression and anxiety 30294451 2018 11 14 2056-4724 4 5 2018 Sep BJPsych open BJPsych Open Demographic and clinical predictors of response to internet-enabled cognitive-behavioural therapy for depression and anxiety. 411-418 10.1192/bjo.2018.57 Common mental health problems affect a quarter of the population. Online cognitive-behavioural therapy (CBT) is increasingly used, but the factors (...) . S.R.C. consults for Cambridge Cognition and Shire. Keywords: Anxiety disorders; cognitive behavioural therapies; depressive disorders; individual psychotherapy. Catarino Ana A Senior Scientist, Clinical Science Laboratory at Ieso, Ieso Digital Health, UK. Bateup Sarah S Chief Clinical Officer, Clinical Science Laboratory at Ieso, Ieso Digital Health, UK. Tablan Valentin V Senior Vice President for Artifical intelligence, Clinical Science Laboratory at Ieso, Ieso Digital Health, UK. Innes Katherine K

BJPsych open2018 Full Text: Link to full Text with Trip Pro

34. Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT

Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} Behavioural activation was no better than a guided self-help intervention at improving depression at 12 months, although both groups improved during the trial. {{author}} {{($index , , , , , , , , , , , , , , , & . Andrew Jahoda 1, * , Richard Hastings 2, 3 , Chris Hatton 4 , Sally-Ann Cooper 1 , Nicola McMeekin 1 , Dave Dagnan 4, 5 , Kim Appleton 1 , Katie Scott 1 , Lauren Fulton 1

NIHR HTA programme2018

35. Randomized Clinical Trial Comparing Procedural Amnesia and Respiratory Depression Between Moderate and Deep Sedation With Propofol in the Emergency Department

Randomized Clinical Trial Comparing Procedural Amnesia and Respiratory Depression Between Moderate and Deep Sedation With Propofol in the Emergency Department 30098230 2018 09 24 1553-2712 2018 Aug 11 Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Acad Emerg Med Randomized Clinical Trial Comparing Procedural Amnesia and Respiratory Depression Between Moderate and Deep Sedation With Propofol in the Emergency Department. 10.1111/acem.13548 (...) depression (RD) was defined as SaO 2 ≤ 91%, change in ETCO 2 ≥ 10 mm Hg, or absent ETCO 2 at any time. The occurrence of RD with a SAM was defined as an ARE. Patient satisfaction, pain, and perceived recollection and physician assessment of procedure difficulty were collected using visual analog scales (VASs). Data were analyzed with descriptive statistics and Wilcoxon rank-sum test. A total of 107 patients were enrolled: 54 randomized to target MS and 53 to DS. Of the patients randomized to target MS

EvidenceUpdates2018

36. Depression in Nonclassical Hypogonadism in Young Men

Depression in Nonclassical Hypogonadism in Young Men 30430144 2018 12 07 2472-1972 2 11 2018 Nov 01 Journal of the Endocrine Society J Endocr Soc Depression in Nonclassical Hypogonadism in Young Men. 1306-1313 10.1210/js.2018-00137 The specific objective of this study was to test the clinically derived hypothesis associating a high prevalence of depression in young men with nonclassical hypogonadism. We studied the entire population of men aged 18 to 40 years who had an outpatient visit (...) at an academic health system in the years 2013 to 2015. The study group comprised 186 patients with a diagnosis of eugonadotropic hypogonadism and a testosterone value below 10.4 nmol/L with no apparent cause. We compared their demographic factors, other diagnoses, and treatments with those of (i) the entire population, (ii) a matched population of 930 controls, and (iii) 404 controls with normal testosterone determinations, and no hypogonadism diagnosis. Depression, defined as either an International

Journal of the Endocrine Society2018 Full Text: Link to full Text with Trip Pro

37. A coping programme moderately reduces depression and anxiety in carers of people with dementia

A coping programme moderately reduces depression and anxiety in carers of people with dementia Signal - A coping programme moderately reduces depression and anxiety in carers of people with dementia Dissemination Centre Discover Portal NIHR DC Discover A coping programme moderately reduces depression and anxiety in carers of people with dementia Published on 28 October 2015 This NIHR-funded trial found that a programme to support carers of people with dementia was moderately effective (...) in reducing carers’ depression and anxiety scores for up to two years. It was also cost-effective. The programme consisted of eight sessions delivered by psychology graduates, covering topics such as managing difficult behaviour, accessing support and planning for the future. One in three people over 65 develop dementia and family are often the primary caregivers. The findings of this trial support NICE recommendations that the psychological burden upon carers is assessed and that they are given support

NIHR Dissemination Centre2018

38. Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus: a health economic evaluation

Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus: a health economic evaluation 30071909 2018 08 03 1472-1465 212 4 2018 Apr The British journal of psychiatry : the journal of mental science Br J Psychiatry Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus: a health economic evaluation. 199-206 10.1192/bjp.2018.10 Web-based interventions are effective in reducing depression. However, the evidence (...) for the cost-effectiveness of these interventions is scarce.AimsThe aim is to assess the cost-effectiveness of a web-based intervention (GET.ON M.E.D.) for individuals with diabetes and comorbid depression compared with an active control group receiving web-based psychoeducation. We conducted a cost-effectiveness analysis with treatment response as the outcome and a cost-utility analysis with quality-adjusted life-years (QALYs) alongside a randomised controlled trial with 260 participants. At a willingness

EvidenceUpdates2018

39. Interventions to Increase Depression Treatment Initiation in Primary Care Patients: a Systematic Review

Interventions to Increase Depression Treatment Initiation in Primary Care Patients: a Systematic Review 30109586 2018 08 21 1525-1497 2018 Aug 14 Journal of general internal medicine J Gen Intern Med Interventions to Increase Depression Treatment Initiation in Primary Care Patients: a Systematic Review. 10.1007/s11606-018-4554-z Nearly 50% of depressed primary care patients referred to mental health services do not initiate mental health treatment. The most promising interventions (...) for increasing depression treatment initiation in primary care settings remain unclear. We performed a systematic search of publicly available databases from inception through August 2017 to identify interventions designed to increase depression treatment initiation. Two authors independently selected, extracted data, and rated risk of bias from included studies. Eligible studies used a randomized or pre-post design and assessed depression treatment initiation (i.e., ≥ 1 mental health visit or antidepressant

EvidenceUpdates2018

40. Antidepressants for treating depression in dementia.

Antidepressants for treating depression in dementia. BACKGROUND: The use of antidepressants in dementia accompanied by depressive symptoms is widespread, but their clinical efficacy is uncertain. This review updates an earlier version, first published in 2002. OBJECTIVES: To determine the efficacy and safety of any type of antidepressant for patients who have been diagnosed as having dementia of any type and depression as defined by recognised criteria. SEARCH METHODS: We searched ALOIS (...) , the Cochrane Dementia and Cognitive Improvement Group's Specialised Register, on 16 August 2017. ALOIS contains information on trials retrieved from databases and from a number of trial registers and grey literature sources. SELECTION CRITERIA: We included all relevant double-blind, randomised trials comparing any antidepressant drug with placebo, for patients diagnosed as having dementia and depression. DATA COLLECTION AND ANALYSIS: Two review authors selected studies for inclusion and extracted data

Cochrane2018